These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29516223)

  • 1. A circadian rhythm-related MTNR1B genetic variant modulates the effect of weight-loss diets on changes in adiposity and body composition: the POUNDS Lost trial.
    Goni L; Sun D; Heianza Y; Wang T; Huang T; Martínez JA; Shang X; Bray GA; Smith SR; Sacks FM; Qi L
    Eur J Nutr; 2019 Jun; 58(4):1381-1389. PubMed ID: 29516223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial.
    Heianza Y; Ma W; Huang T; Wang T; Zheng Y; Smith SR; Bray GA; Sacks FM; Qi L
    Diabetes Care; 2016 Nov; 39(11):1909-1914. PubMed ID: 27581055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A circadian rhythm-related MTNR1B genetic variant (rs10830963) modulate body weight change and insulin resistance after 9 months of a high protein/low carbohydrate vs a standard hypocaloric diet.
    de Luis DA; Izaola O; Primo D; Aller R
    J Diabetes Complications; 2020 Apr; 34(4):107534. PubMed ID: 32057567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macronutrient-specific effect of the
    Goni L; Sun D; Heianza Y; Wang T; Huang T; Cuervo M; Martínez JA; Shang X; Bray GA; Sacks FM; Qi L
    J Lipid Res; 2018 Jan; 59(1):155-161. PubMed ID: 29089366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the rs10830963 polymorphism in melatonin receptor type 1B (MTNR1B) with metabolic response after weight loss secondary to a hypocaloric diet based in Mediterranean style.
    de Luis DA; Izaola O; Primo D; Aller R
    Clin Nutr; 2018 Oct; 37(5):1563-1568. PubMed ID: 28869073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants in glucose- and circadian rhythm-related genes affect the response of energy expenditure to weight-loss diets: the POUNDS LOST Trial.
    Mirzaei K; Xu M; Qi Q; de Jonge L; Bray GA; Sacks F; Qi L
    Am J Clin Nutr; 2014 Feb; 99(2):392-9. PubMed ID: 24335056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary-fat effect of the rs10830963 polymorphism in MTNR1B on insulin resistance in response to 3 months weight-loss diets.
    de Luis DA; Izaola O; Primo D; Aller R
    Endocrinol Diabetes Nutr (Engl Ed); 2020 Jan; 67(1):43-52. PubMed ID: 30981681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-Gene Interplay and Gene-Diet Interactions Involving the MTNR1B rs10830963 Variant with Body Weight Loss.
    Goni L; Cuervo M; Milagro FI; Martínez JA
    J Nutrigenet Nutrigenomics; 2014; 7(4-6):232-42. PubMed ID: 25870980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A circadian rhythm-related MTNR1B genetic variant (rs10830963) modulates glucose metabolism and insulin resistance after body weight loss secondary to biliopancreatic diversion surgery.
    Pacheco D; Izaola Jáuregui O; Primo Martín D; de Luis Román DA
    Nutr Hosp; 2020 Dec; 37(6):1143-1149. PubMed ID: 33119394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-microbiome-related LCT genotype and 2-year changes in body composition and fat distribution: the POUNDS Lost Trial.
    Heianza Y; Sun D; Ma W; Zheng Y; Champagne CM; Bray GA; Sacks FM; Qi L
    Int J Obes (Lond); 2018 Sep; 42(9):1565-1573. PubMed ID: 29568104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial.
    Heianza Y; Zhou T; Wang X; Furtado JD; Appel LJ; Sacks FM; Qi L
    Diabetologia; 2024 Mar; 67(3):506-515. PubMed ID: 38052941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between an
    Goni L; Riezu-Boj JI; Milagro FI; Corrales FJ; Ortiz L; Cuervo M; Martínez JA
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29921800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention.
    Mattei J; Qi Q; Hu FB; Sacks FM; Qi L
    Am J Clin Nutr; 2012 Nov; 96(5):1129-36. PubMed ID: 23034957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial.
    Zhang X; Qi Q; Zhang C; Smith SR; Hu FB; Sacks FM; Bray GA; Qi L
    Diabetes; 2012 Nov; 61(11):3005-11. PubMed ID: 22891219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a MTNR1B gene variant with fasting glucose and HOMA-B in children and adolescents with high BMI-SDS.
    Holzapfel C; Siegrist M; Rank M; Langhof H; Grallert H; Baumert J; Irimie C; Klopp N; Wolfarth B; Illig T; Hauner H; Halle M
    Eur J Endocrinol; 2011 Feb; 164(2):205-12. PubMed ID: 21059861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CB2R) on metabolic and adiposity parameters after weight loss with two hypocaloric diets.
    de Luis DA; Mulero I; Primo D; Izaola O; Aller R
    Diabetes Res Clin Pract; 2018 May; 139():339-347. PubMed ID: 29518488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial.
    Qi Q; Bray GA; Smith SR; Hu FB; Sacks FM; Qi L
    Circulation; 2011 Aug; 124(5):563-71. PubMed ID: 21747052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trial.
    Lin X; Qi Q; Zheng Y; Huang T; Lathrop M; Zelenika D; Bray GA; Sacks FM; Liang L; Qi L
    Am J Clin Nutr; 2015 Aug; 102(2):514-9. PubMed ID: 26156739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: the POUNDS LOST trial.
    Qi Q; Xu M; Wu H; Liang L; Champagne CM; Bray GA; Sacks FM; Qi L
    Diabetes Care; 2013 Nov; 36(11):3442-7. PubMed ID: 24009303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial.
    Qi Q; Bray GA; Hu FB; Sacks FM; Qi L
    Am J Clin Nutr; 2012 Feb; 95(2):506-13. PubMed ID: 22237064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.